Q2 2019 Matinas BioPharma Holdings Inc Earnings Call Transcript
Greetings and welcome to the Matinas BioPharma quarterly update conference call and webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Peter Vozzo of Westwicke, Investor Relations for Matinas BioPharma. Please go ahead, Peter.
Thank you, Kevin. Good morning, everyone, and thank you for joining the Matinas BioPharma second quarter results conference call.
Earlier this morning, we issued a press release with our second quarter 2019 financial results along with business updates. The release is available on the Matinas BioPharma website under the Investors section.
Joining me on the call today are Jerry Jabbour, Chief Executive Officer; Dr. Terry Ferguson, Chief Medical Officer; Dr. Terri Matkovits, Chief Development Officer; and Dr. Raphael Mannino, Chief Scientific Officer; and Keith Kucinski, Chief Financial Officer.
At this time, I would like to remind our listeners that remarks made during this call may
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |